Clinical Trial

Open Space and Closed Years

Study acronym: OS&CY
Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated January 26, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The primary objective of this project is to examine the effects of a specific multicomponent physical activity program (MPAP), conducted in an outdoor setting, on the health and functional-motor status (HFMS) of women over the age of 60. Additionally, the study will investigate the influence of sociodemographic factors (SDF), physical literacy (PL), and health literacy (HL) on the baseline HFMS and the subsequent changes resulting from the KTP. Study Methodology The program participants will consist of older women (\>60 years; n=60) whose current HFMS allows for participation in the exercise protocol. They will be divided into two groups: Experimental Group: Will participate in the MPAP. Control Group: Will not participate in the MPAP. The exercise intervention (MPAP) will include a combination of aerobic activities, strength exercises, balance, and flexibility. It will be conducted two to three times per week across two three-month cycles, separated by a three-month break. Data Collection and Environment Assessments: Sociodemographic factors, physical literacy, and health literacy will be measured at the start of the study. A series of HFMS indicators will be recorded before and after each exercise cycle. Setting: The MPAP will be performed outdoors in a public park. Project Significance Beyond analyzing the direct effects of the exercise program and the correlations between the measured variables, this project will contribute to a deeper understanding of the importance of the natural environment in implementing goal-oriented physical activity for the elderly population.
Trial Details
NCT Number NCT07365228
Lead Sponsor Goran Kuvacic
Conditions Physical Fitness, Health Literacy, Lipid Profile, Body Composition, Physical Literacy
Enrollment 150 participants
Start Date 2026-01-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2029-06-01 (estimated)
Updated on ClinicalTrials.gov 2026-01-26